These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective. Thomas R; Kermode AR Mol Genet Metab; 2019 Feb; 126(2):83-97. PubMed ID: 30528228 [TBL] [Abstract][Full Text] [Related]
9. Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenges. Köse S; Aerts-Kaya F; Uçkan Çetinkaya D; Korkusuz P Adv Exp Med Biol; 2021; 1347():135-162. PubMed ID: 33977438 [TBL] [Abstract][Full Text] [Related]
10. AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement. Nascimbeni F; Dionisi Vici C; Vespasiani Gentilucci U; Angelico F; Nobili V; Petta S; Valenti L; Dig Liver Dis; 2020 Apr; 52(4):359-367. PubMed ID: 31902560 [TBL] [Abstract][Full Text] [Related]
11. Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem. Macauley SL Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1(Suppl 1):639-48. PubMed ID: 27491211 [TBL] [Abstract][Full Text] [Related]
12. Evolving therapies in neuronopathic LSDs: opportunities and challenges. Rajan DS; Escolar ML Metab Brain Dis; 2022 Oct; 37(7):2245-2256. PubMed ID: 35442005 [TBL] [Abstract][Full Text] [Related]